Disabling the platelet's brakes to promote thrombosis. Blood 2015 Apr 23;125(17):2591-3
Date
04/25/2015Pubmed ID
25907902DOI
10.1182/blood-2015-03-630822Scopus ID
2-s2.0-84928317219 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
In this issue of Blood, Magwenzi et al from the University of Hull report a novel mechanistic connection between oxidized low-density lipoprotein (oxLDL)-induced prothrombotic platelet signaling and the inhibition of endogenous platelet anti-activating signaling mediated by the nitric oxide (NO)/guanosine 3′,5′-cyclic monophosphate (cGMP)/protein kinase G (PKG) pathway.
Author List
Silverstein RLAuthor
Roy L. Silverstein MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsBlood Platelets
CD36 Antigens
Cyclic GMP-Dependent Protein Kinases
Humans
Lipoproteins, LDL
Membrane Glycoproteins
NADPH Oxidases
Signal Transduction